|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03084094 |
|
Date of registration:
|
07/03/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Neuromodulation and Its Therapeutic Potentiality in Different Populations
|
|
Scientific title:
|
Transcranial Direct Current Stimulation and Its Therapeutic Potentiality in Different Populations |
|
Date of first enrolment:
|
October 17, 2016 |
|
Target sample size:
|
45 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03084094 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Brazil
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Female gender aged from 18 to 65 year old, having a clinical diagnosis of Fibromyalgia
given by a rheumatologist.
Exclusion Criteria:
- Non-regulated psychiatric disorders (bipolar, main depression, schizophrenia)
- Performing other types of treatment during the research
- Performing physical activities
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Fibromyalgia
|
|
Intervention(s)
|
|
Device: Transcranial Direct Current Stimulation
|
|
Primary Outcome(s)
|
|
Change from Baseline Pain at 5 weeks
[Time Frame: 1 week prior to treatment, day 1 of treatment, last day of treatment (day 5), 7 days, 14 days and 21 days after treatment]
|
|
Change from Baseline Pain at 2 weeks
[Time Frame: 1 week prior to treatment (Baseline) and 1 week during treatment]
|
|
Secondary Outcome(s)
|
|
Functional Capacity
[Time Frame: 1 week prior to treatment, last day of treatment (day 5),7 days, 14 days and 21 days after treatment]
|
|
Mood
[Time Frame: 1 week prior to treatment, last day of treatment (day 5),7 days, 14 days and 21 days after treatment]
|
|
Anxiety
[Time Frame: 1 week prior to treatment, last day of treatment (day 5),7 days, 14 days and 21 days after treatment]
|
|
Positive and negative affect
[Time Frame: 1 week prior to treatment, last day of treatment (day 5),7 days, 14 days and 21 days after treatment]
|
|
Secondary ID(s)
|
|
tDCS in fibromyalgia
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|